About
Azadeh Golipour is a biotech executive focused on cell and gene therapy technical development, CMC strategy, and manufacturing. AVROBIO's 2023 Form 10-K says she became Chief Technology Officer in January 2022 after holding multiple senior roles at the company since 2016. Company materials also state that before AVROBIO she worked at CCRM on due diligence, business planning, and program leadership for cell-therapy spinouts, and that her stem-cell research has been published in Cell Stem Cell and Nature.
Areas of interest
biotechcell therapygene therapygenetic medicinesCMCtechnical developmenttechnical operationsGMP manufacturingregulatory strategyregenerative medicinestem cell biology